PC

Prostate Cancer and Prostatic Diseases

Prostate Cancer and Prostatic Diseases is a journal focused on prostate cancer and prostatic diseases, publishing content including articles, review articles, perspectives, editorials, and correspondence. The journal is published on the Nature platform and includes both subscription and Open Access articles. It is a member of and subscribes to the principles of the Committee on Publication Ethics.

Looking to publish in Prostate Cancer and Prostatic Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology, Urology & Nephrology
Impact Factor 5.8
Quartile Q1
Open Access Type Hybrid
ISSN 1365-7852
eISSN 1476-5608
Invitation Only No
Cost Range Open access APC: £3790.00 / $5490.00 / €4490.00, subject to VAT or local taxes where applicable; traditional publishing model: no APC.

Submission Instructions

Prostate Cancer and Prostatic Diseases accepts the following article types. Click on an article type to view submission instructions.

Article

Cover Letter A cover letter is required. Cover letter must provide the corresponding author's affiliation and contact information, briefly explain the importance of the work and its suitability for the journal's diverse readership, confirm originality, and include a competing interests statement.
Abstract A structured abstract is required. Abstract must not exceed 300 words. Abstract must be structured. Abstract must use the headings BACKGROUND, METHODS, RESULTS, and CONCLUSIONS.
Manuscript Main body of text including the abstract must not exceed 3,000 words. Article submissions must follow the required article structure and include Methods sufficient for reproduction of the experimental procedures. Manuscript must include a Data Availability Statement, document any use of a large language model in the Methods section or suitable alternative section, and include a Competing Interests statement before the References section.
References References must not exceed 50. References must follow Vancouver format. References must be numbered in order of citation and listed in numerical order, with up to six authors listed in full and the first six followed by et al. when there are more than six authors.
Figures & Tables Articles may include a maximum of 5 tables or figures. Figures must be uploaded as separate files rather than embedded in the text, and each table must be uploaded as a separate file. Figure legends must be provided on a separate manuscript page after the References section, and all tables must be editable.
Reformat to Prostate Cancer and Prostatic Diseases using Livewrite Premium

Systematic Reviews

Cover Letter A cover letter is required. Cover letter must provide the corresponding author’s affiliation and contact information, explain the importance of the work and its suitability for the journal’s diverse readership, confirm originality, and include a Competing Interests statement.
Abstract A structured abstract is required. Abstract must not exceed 300 words. Abstract must be structured. Abstract must include the headings BACKGROUND, METHODS, RESULTS, and CONCLUSIONS.
Manuscript Main body text, including the abstract, must not exceed 4,500 words. Systematic Reviews must include background, methods, results, and conclusion sections, and the Methods section must report the citation indexes and databases searched to generate the review content. Use of a large language model must be documented in the Methods section or another suitable part of the manuscript if no Methods section is available.
References Systematic Reviews may include a maximum of 100 references. References must follow Vancouver format. References must be numbered in citation order and listed in double-spaced numerical order at the end of the paper, with up to six authors listed in full and more than six shortened to the first six followed by et al.
Figures & Tables Tables must be uploaded as separate files and figures must not be embedded in the text but uploaded as separate files. All tables must be editable and each table and figure must be labelled sequentially and cited in the text in the correct order.
Reformat to Prostate Cancer and Prostatic Diseases using Livewrite Premium

Review Article

Cover Letter Cover Letter requirements are not specified.
Abstract Review Articles must include a structured abstract. Abstract must not exceed 300 words. Abstract must be structured. Abstract must use the headings BACKGROUND, METHODS, RESULTS, and CONCLUSIONS.
Manuscript Review Articles must not exceed 4,500 words for the main body of text including the abstract. Use of a large language model must be documented in the Methods section, or in a suitable alternative part of the manuscript if a Methods section is not available.
References Review Articles may include a maximum of 100 references. References must follow the Vancouver format. References must be numbered in order of citation and listed at the end of the paper in numerical order, with all authors listed for papers with up to six authors and the first six followed by et al. for papers with more than six authors.
Figures & Tables Figures must not be embedded within the text and must be uploaded as separate files, and each table must be uploaded as a separate file. All tables must be editable.
Reformat to Prostate Cancer and Prostatic Diseases using Livewrite Premium

Brief Communication

Cover Letter A cover letter is required. Cover letter must include the corresponding author's affiliation and contact information, briefly explain the importance of the work and its suitability for the journal's diverse readership, confirm originality, and include a Competing Interests statement.
Abstract A structured summary is required. Abstract must not exceed 100 words. Abstract must be structured. Abstract headings must be BACKGROUND, METHODS, RESULTS, and CONCLUSIONS.
Manuscript Main body text must not exceed 1,000 words including the abstract. Any use of a large language model must be documented in the Methods section or in another suitable part of the manuscript if no Methods section is available.
References References must not exceed 10. References must follow Vancouver format. References must be numbered in order of citation and listed in double-spaced numerical order, with up to six authors listed in full and more than six shortened to the first six followed by et al.
Figures & Tables Brief Communications may include a maximum of 1 table or figure. Figures must not be embedded within the text and must be uploaded as separate files, and each table must be uploaded as a separate file. Tables must be editable and figure legends must appear on a separate manuscript page after the References section.
Reformat to Prostate Cancer and Prostatic Diseases using Livewrite Premium

Correspondence

Cover Letter A cover letter is required. Cover letter must provide the corresponding author's affiliation and contact information, briefly explain the importance of the work and its relevance to the journal's diverse readership, confirm originality, and include a Competing Interests statement.
Abstract Abstract must not be included.
Manuscript Main body of text must not exceed 750 words. Any use of a large language model must be documented in the Methods section or, if no Methods section is available, in another suitable part of the manuscript.
References References are limited to a maximum of 5. References must follow Vancouver format. References must be numbered in order of citation and listed in double-spaced numerical order at the end, with up to six authors listed in full and more than six truncated after the first six with et al.
Figures & Tables Correspondence may include a maximum of 1 table or figure. Figures must be uploaded as separate files rather than embedded in the text, and each table must be uploaded as a separate file. Tables must be editable and figures and tables must be labelled sequentially and cited in the text.
Reformat to Prostate Cancer and Prostatic Diseases using Livewrite Premium

Recent Publications

Association between concomitant ACEI/ARBs use and survival of patients with prostate cancer receiving abiraterone acetate: A post-hoc analysis of two randomized trials

Junliang Zhao, Xinyang Cai, Zijun Mo, Diwei Zhao, Jun Wang, Zhenyu Yang, Xingbo Long, Yuanwei Li, Dong Chen, Jitong Li, Zhaohui Zhou, Shigeng Li, Yonghong Li

10.1038/s41391-026-01128-1
View Publication

Zenflow spring system for benign prostatic hyperplasia - 24 month outcomes of the ZEST pilot studies

Peter Gilling, Peter Chin, Paul Anderson, Kevin Zorn, Edward D. Matsumoto, William Lynch, Lewis Chan, Henry Woo, Rodrigo Pérez Becerra, Janelle Brennan, Dean Elterman

10.1038/s41391-026-01126-3
View Publication

Insights gained from single-cell transcriptomics on the cellular identity and plasticity of prostate epithelial cells

Megan Hess Check, Karen S. Sfanos

10.1038/s41391-026-01127-2
View Publication

Biochemical recurrence after radical prostatectomy: Where do we stand to?

Rolando Maria D’Angelillo, Luca Eolo Trodella, Michele Fiore, Edy Ippolito, Carlo Greco, Sara Ramella

10.1038/s41391-026-01125-4
View Publication

EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression

Fabio Turco, Silke Gillessen, Giuseppe Salfi, Iris S. H. Kloots, Peter H. J. Slootbeek, Niven Mehra, Matthew Labriola, Daniel J. George, Amanda Broderick, Anna Patrikidou, Hortense Patry, Consuelo Buttigliero, Veronica Crespi, Hirotsugu Uemura, Kazutoshi Fujita, Takanobu Utsumi, Hiroyoshi Suzuki, Daniele Raggi, Umberto Basso, Rafael Morales-Barrera, David Marmolejo Castaneda, Cora N. Sternberg, Daniela Guevara, Orazio Caffo, Giuseppe Procopio, Andrea Zivi, Sara Merler, Mariella Sorarù, Daniel E. Spratt, Pedro C. Barata, Carlo Messina, Yüksel ürün, Hatice Bolek, Ignacio Duràn, Juan Diego Cacho Lavin, Nieves Martínez Chanzá, Lisa G. Horvath, Rhiannon Mellor, Levent Türkeri, Merve Bengisu Soykök, Sabrina Rossetti, Richard Cathomas, Giuseppe Luigi Banna, Vincenza Conteduca, Margaret Ottaviano, Laura Marandino, Hui-Ming Lin, Luigi Tortola, Ricardo Pereira Mestre, Martino Pedrani

10.1038/s41391-026-01124-5
View Publication

Frequently asked questions

How long does it take to publish?

Reviewers are given 14 days from acceptance to submit their reports. For revisions, authors may be asked to address reviewer concerns within six months or less. Proof corrections must be returned within 48 hours of receipt. Accepted manuscripts are published online in advance of print.

Reformat to Prostate Cancer and Prostatic Diseases using Livewrite Premium

Is a cover letter required?

A cover letter is required. It should include the corresponding author’s affiliation and contact information, explain the importance of the work and its suitability for the journal’s readership, confirm the work is original, unpublished, and not under consideration elsewhere, include previous reviewer comments if the manuscript was considered by another journal, and include a Competing Interests statement.

Reformat to Prostate Cancer and Prostatic Diseases using Livewrite Premium

What are the publication costs?

Open access APC: £3790.00 / $5490.00 / €4490.00, subject to VAT or local taxes where applicable. Traditional publishing model: no APC.

Reformat to Prostate Cancer and Prostatic Diseases using Livewrite Premium

Research Topics

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Urinary Bladder and Prostate Research Cancer, Lipids, and Metabolism Hormonal and reproductive studies Urologic and reproductive health conditions Advanced Radiotherapy Techniques Pelvic floor disorders treatments Radiopharmaceutical Chemistry and Applications Cancer survivorship and care Bone health and treatments Bladder and Urothelial Cancer Treatments Sexual function and dysfunction studies Urinary Tract Infections Management Global Cancer Incidence and Screening MRI in cancer diagnosis Inflammatory Biomarkers in Disease Prognosis Estrogen and related hormone effects Metabolism, Diabetes, and Cancer Urological Disorders and Treatments Genital Health and Disease Cancer Risks and Factors Cancer Immunotherapy and Biomarkers Molecular Biology Techniques and Applications Cancer Genomics and Diagnostics

Related Journals

IJ
International Journal of Oral Science Springer Nature
AJ
American Journal of Cancer Research e-Century Publishing Corporation
PN
Pediatric Nephrology Springer Science+Business Media
EJ
European Journal of Cancer Elsevier BV
CN
Cancer Nanotechnology BioMed Central
TA
Therapeutic Advances in Medical Oncology SAGE Publishing